Delos Wealth Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95.9K Sell
208
-2
-1% -$1.01K 0.05% 106
2025
Q4
$119K Hold
210
0.08% 67
2025
Q3
$93.9K Hold
210
0.06% 81
2025
Q2
$114K Buy
+210
New +$110K 0.09% 67
2025
Q1
Sell
-7
Closed -$3.65K 114
2024
Q4
$3.65K Hold
7
﹤0.01% 146
2024
Q3
$3.44K Sell
7
-60
-90% -$27.9K ﹤0.01% 141
2024
Q2
$29.8K Sell
67
-5
-7% -$1.99K 0.03% 89
2024
Q1
$28.7K Buy
72
+57
+380% +$21.5K 0.03% 81
2023
Q4
$5.06K Hold
15
0.01% 111
2023
Q3
$4.69K Hold
15
0.01% 160
2023
Q2
$5.13K Hold
15
0.01% 156
2023
Q1
$3.83K Hold
15
﹤0.01% 166
2022
Q4
$3.98K Hold
15
0.01% 179
2022
Q3
$3K Buy
15
+3
+25% +$644 ﹤0.01% 184
2022
Q2
$2K Sell
12
-249
-95% -$58.4K ﹤0.01% 194
2022
Q1
$79K Hold
261
0.08% 62
2021
Q4
$94K Buy
261
+51
+24% +$17.5K 0.09% 52
2021
Q3
$70K Buy
210
+198
+1,650% +$66.5K 0.08% 50
2021
Q2
$4K Buy
+12
New +$3.37K 0.01% 117

Other funds holding ISRG

Delos Wealth Advisors's ISRG Position: Q1 2026 in Review

Delos Wealth Advisors reduced its Intuitive Surgical (ISRG) stake by 0.95% in Q1 2026, selling an estimated $1.01K and leaving 208 shares worth $95.9K. The position accounts for 0.05% of the portfolio, ranked #106.

Delos Wealth Advisors first reported a position in ISRG in Q2 2021 and has held it in 19 quarters since. The position peaked at $119K in Q4 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Delos Wealth Advisors held 208 shares of Intuitive Surgical worth $95.9K as of Q1 2026.
  • Delos Wealth Advisors sold 2 Intuitive Surgical shares in Q1 2026, an estimated $1.01K.
  • Intuitive Surgical made up 0.05% of Delos Wealth Advisors's portfolio in Q1 2026, its #106 holding.
  • Delos Wealth Advisors first reported a position in Intuitive Surgical in Q2 2021 and has held it in 19 quarters since.
  • Delos Wealth Advisors's Intuitive Surgical position peaked at $119K in Q4 2025.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Delos Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.